Search

everythinglearnresearchcommunity

for

Search:↓

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

Parathyroid hormone-related protein helps control hair growth phases in mice.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

MicroRNAs play a crucial role in skin and hair health, affecting everything from growth to aging, and could potentially be used in treating skin diseases.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

PRP treatment helps hair growth and density with 70.7% success, but more research needed.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Loose Anagen Syndrome causes easy-to-pull, thin hair, mainly in young girls, and improves with age.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

Genomic approach finds new possible treatments for hair loss.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Hairless mammals have genetic changes in both their protein-coding and regulatory sequences related to hair.

PRP might help with hair growth and skin rejuvenation, but more research is needed to prove its effectiveness.

The gene Ascl4 is not necessary for the development of hair, teeth, or mammary glands.

Excess androgens may cause PCOS, not just be a symptom.

Effective PCOS treatments require targeting specific signaling pathways.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Water extract of Cacumen Platycladi helps hair growth by activating specific cell pathways.

Amniotic allograft may be more effective than platelet-rich plasma for midface aging treatment.